Clinical trials
2 active studies led by OpalGenix, Inc, of 2 in all
Source: ClinicalTrials.gov, Studies with OpalGenix, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show OpalGenix, Inc in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by OpalGenix, Inc or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by OpalGenix, Inc, of 2 in all
Source: ClinicalTrials.gov, Studies with OpalGenix, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show OpalGenix, Inc: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets OpalGenix, Inc is in.
Stories on the topics OpalGenix, Inc works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read